• Explore /
  • Poster
  • / Efficacy of PD-1 monoclonal antibody SHR-1210 plus apatinib in patients with advanced non-squamous NSCLC with wild‐type EGFR and ALK.

Efficacy of PD-1 monoclonal antibody SHR-1210 plus apatinib in patients with advanced non-squamous NSCLC with wild‐type EGFR and ALK.

Abstract Poster

Authors

null

Caicun Zhou

Pulmonary Hospital of Tongji University, Shanghai, China

Caicun Zhou , Guanghui Gao , Yi Na Wang , Jun Zhao , Gongyan Chen , Zhihua Liu , Kangsheng Gu , Meijuan Huang , Jianxing He , Jianhua Chen , Zhiyong Ma , Ji Feng Feng , Jianhua Shi , Quanren Wang , Ying Yang , Xinmin Yu , Ying Cheng , Yu Yao , Shengxiang Ren

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03083041

Citation

J Clin Oncol 37, 2019 (suppl; abstr 9112)

DOI

10.1200/JCO.2019.37.15_suppl.9112

Abstract #

9112

Poster Bd #

435

Abstract Disclosures

Similar Posters

First Author: Tony S. K. Mok

First Author: Lin Wu

First Author: Xuan Wang

First Author: Mingfang Zhao